THE ESSENTIAL BIOTECH INVESTMENT GUIDE

Dr C Mark Tang has followed and invested in the life sciences biotech industry for over a decade. He has been a senior biotechnology analyst, venture capitalist, wealth management advisor, and Publisher of Bio/Medical Technology Stock Newsletter. Dr Tang has also worked for several investment banks including UBS PaineWebber and Morgan Stanley Dean Witter in New York, and currently heads a healthcare life sciences venture investment firm in the United States.

This invaluable book tells the reader how to invest in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. He holds an MBA in Finance and a PhD in Biochemistry.

Contents:

Biotech Stock for Wealth Growth: An Essential Portion of Asset
The Basics of Investing
An Introduction to Biotechnology and Genomics
Understanding Biotechnology Invention and the FDA Approval Process
Introduction to Biotechnology Investing
How to Value and Invest in a Biotech Company
Investing in Biotechnology Mutual Funds
Healthcare Biotech Index Investing: Strategies Using Exchange-Traded-Funds (ETFs), Biotech iShares, and BOXES
Risk Management Consideration for Biotech Investors with Concentrated Equity Positions
Managing Biotech Stock Options: Your Employee Benefits
An Introduction to Healthcare Biotechnology Hedge Fund Investing
An Introduction to Healthcare Biotechnology Private Equity Investing
Retirement Planning Considerations for Biotech Executives and Investors
Charitable Disposition of Appreciated Biotech Stocks
Managing Your Biotech Wealth–Estate Planning for Biotech Investors, Executives, and Founders

Readership: Individual biotechnology investors, investment advisors/professionals, venture capitalists, entrepreneurs, portfolio managers, scientists, CPAs, legal professionals, industry analysts and graduate students.

“This book is resourceful in both areas of finance and technology, unraveling their respective roles and functions within the intricate web of biotechnology industry. It gives a well-rounded, easy-to-understand description of the scientific bases constituting the business, and the various ways to evaluate the worth and potential of different biotech companies. The book is recommended not only for private investors and biotech fund managers hoping to understand the dynamics of the life sciences sector and identify the winner, but also to executives as a desk reference and scientists working in the biotech industry who may want to form their own biotech companies someday.”

Dr Shawn Leung
Managing Director
Hong Kong Institute of Biotechnology

“Very comprehensive. Best biotech investment book of the year.”

Nancy Chang
CEO
Tanox Biosystems, Inc., USA

“An excellent guide to the fundamentals of investing in the health care sector. C Mark Tang's financial and scientific expertise lend his analysis and opinion a reassuring authoritativeness.”

Michael Francisco
Associate Editor
Nature Biotechnology

284pp		Pub. date: Dec 2002
ISBN: 978-981-238-138-5 981-238-138-4		US$51 / £38

284pp		Pub. date: Dec 2002
ISBN: 978-981-238-139-2(pbk) 981-238-139-2(pbk)		US$30 / £22

284pp		Pub. date: Dec 2002
ISBN: 978-981-277-668-6(ebook) 981-277-668-0(ebook)		US$66 / £N/A

Imperial College Press \| Global Publishing \| Asia-Pacific Biotech News \| Innovation Magazine Labcreations Co \| Meeting Matters \| National Academies Press Copyright © 2009 World Scientific Publishing Co. All rights reserved. Updated on 20 November 2009